Home › Thrombocytopenia › New York
Thrombocytopenia clinical trials in New York
4 studies for Thrombocytopenia are looking for participants at sites in New York.
Cities in New York
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235Neonatal Platelet Transfusion Threshold Trial
- University of Rochester, Rochester
RecruitingHealthy volunteers welcome
1 Hour – 48 Hours · All sexes · Updated Mar 25, 2026 · NCT06676904Luspatercept for Clonal Cytopenias of Uncertain Significance
- Weill Cornell Medical College, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 24, 2026 · NCT06788691A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- Weill Cornell Medicine NewYork-Presbyterian, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 12, 2026 · NCT05980806From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.